EMP2 and Endometrial Cancer
Author Information
Author(s): Fu Maoyong, Rao Rajiv, Sudhakar Deepthi, Hogue Claire P., Rutta Zach, Morales Shawn, Gordon Lynn K., Braun Jonathan, Goodglick Lee, Wadehra Madhuri
Primary Institution: University of California Los Angeles
Hypothesis
Does EMP2 expression contribute to endometrial tumor formation and migration?
Conclusion
The study found that EMP2 expression is necessary for efficient endometrial tumor formation and promotes cancer cell migration through activation of FAK and Src signaling pathways.
Supporting Evidence
- Endometrial tumors with high levels of EMP2 are more aggressive and correlate with poor clinical outcomes.
- HEC-1A tumors with increased EMP2 expression exhibit a two-fold increase in tumor volume compared to control.
- Reduction of EMP2 expression leads to a three-fold decrease in tumor growth.
Takeaway
This study shows that a protein called EMP2 helps endometrial cancer cells grow and move around, which can make the cancer worse.
Methodology
The study used xenograft models in mice and various cell lines to analyze the effects of EMP2 on tumor growth and migration.
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website